Table 4.
Ligand | Affinity (Ki) [nM] | Ki [ligand]/Ki [SalA] | Reference |
---|---|---|---|
2 (SalB) | 155 ± 23 c | 119 | [38] |
>10,000 a | - | [72] | |
111 ± 12 c | 85 | [71] | |
155 ± 23 c | 119 | [73] | |
280 ± 20 d | 147 | [47] | |
>10,000 b | - | [68] | |
3 | >10,000 a | - | [72] |
4 | >10,000 a | - | [72] |
>10,000 c | - | [71] | |
5 | 17.6 ± 3.1 c | 14 | [73] |
6 | 0.32 ± 0.02 c | 0.133 | [69] |
3.13 ± 0.40 b | 0.423 | [70] | |
7 (RB-64) | 0.59 ± 0.21 b | 0.328 | [55] |
39 ± 11 c | 2 | [55] | |
0.6 ± 0.2 b | 0.097 | [68] | |
8 | >10,000 c | - | [74] |
>1000 c | - | [58] | |
>1000 c | - | [59] | |
9 | >10,000 c | - | [73] |
10 | 28.5 ± 0.9 c | 22 | [58] |
11 | >1000 c | - | [58] |
12 | 3400 ± 150 d | 1789 | [42] |
13 | 55 ± 23 c | 22 | [41] |
14 | 40 ± 1 b | 5 | [75] |
15 | 2.9 ± 0.3 c | 1 | [41] |
3.0 ± 0.2 d | 2 | [42] | |
16 | >8000 b | - | [76] |
17 | 6 ± 1 b | 2 | [77] |
18 | 18 ± 2 b | 5 | [77] |
19 | 1125 ± 365 b | 281 | [77] |
a Ki determined against [3H]bremazocine. b Ki determined against [3H]U69,593. c Ki determined against [3H]diprenorphine. d Ki determined against [125I]IOXY.